Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Developing Methods for Observing Awe Narration in Psilocybin-Assisted TherapyHealthcare · 2026-06-04Bringing Psilocybin-Assisted Therapy to Palliative Oncology: Early Lessons from Real-World ImplementationHealthcare · 2026-06-02Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31Characterizing psilocybin’s effects on nociception and thermoregulation in preclinical pain modelsStanford Digital Repository · 2026-04-29A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depressionNature Mental Health · 2026-04-05Associations Between Psilocybin Use Motives and Cognitive, Affective, and Behavioural Self-StigmaSubstance Use & Misuse · 2026-03-27The role of therapeutic alliance in psilocybin treatment for treatment-resistant depression: A post hoc path analysisJournal of Affective Disorders · 2026-03-22Regulatory ambiguity and governance challenges for psilocybin mushrooms in BrazilInternational Journal of Drug Policy · 2026-02-17Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure RisksUnknown journal · 2025-12-28Advances in Psychedelic Therapeutics: Multimodal Iboga Analogs, EEG-Guided Psilocybin Dosing, and Optimized Harmine-DMT FormulationsACS Medicinal Chemistry Letters · 2025-12-15CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-10-31Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted TherapyHealthcare · 2025-09-11Exploring serotonergic psychedelics as a treatment for personality disorders.Neuropharmacology · 2025-06-30Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World ReligionsPsychedelic Medicine · 2025-05-15Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative CarePalliative Medicine Reports · 2025-04-16Psilocybin Has No Analgesic Properties in Multiple Mouse Models of Acute and Chronic PainJournal of Pain · 2025-03-31Age- and estrous-dependent effects of psilocybin in ratsbioRxiv · 2025-01-13The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory DiscussionsInternational journal of medicinal mushrooms · 2024-11-04Psilocybin alters the circulating metabolomic profile in both non-clinical and clinical modelsBrain Behavior and Immunity · 2024-10-31Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussionsmedRxiv · 2024-07-11Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry methodJournal of Chromatography A · 2024-07-03Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushroomsBritish Journal of Pharmacology · 2024-06-01Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trialScientific Reports · 2024-04-16Magic mushroom and zebrafish: A new recipe?Lab Animal · 2024-03-10Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative studyScientific Reports · 2024-02-04Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based surveyPalliative Medicine · 2024-01-21Anxiolytic behavior accompanied by the alteration of the intestinal bacteriome during psilocybin treatmentBrain Behavior and Immunity · 2023-10-31Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-22Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-13Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-13Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiencesScientific Reports · 2023-08-21Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility StudyJournal of Palliative Medicine · 2023-08-16Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memoriesPsychopharmacology · 2023-06-01Personality change in a trial of psilocybin therapy v. escitalopram treatment for depressionPsychological Medicine · 2023-06-01Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeJournal of Affective Disorders · 2023-02-02Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31Experiences With Sacred Mushrooms and Psilocybin In Dialogue: Transdisciplinary Interpretations Of The “Velada”Anthropology of Consciousness · 2022-08-08Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examplesActa Crystallographica Section A Foundations and Advances · 2022-07-28The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-AnalysisCurrent Psychiatry Research and Reviews · 2022-05-15Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30Psilocybin: Characterization of the Metastable Zone Width (MSZW), Control of Anhydrous Polymorphs, and Particle Size Distribution (PSD).ACS Omega · 2022-02-06Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation.Frontiers in Neuroergonomics · 2022-01-19Psilocybin: crystal structure solutions enable phase analysis of prior art and recently patented examples.Acta Crystallographica Section C Structural Chemistry · 2021-12-31A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.The International Journal of Neuropsychopharmacology · 2021-08-31Effects of Psilocybin on Suicidal Ideation in Patients With Life-Threatening CancerBiological Psychiatry · 2021-04-26Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31Chemoenzymatic Synthesis of 5-Methylpsilocybin: A Tryptamine with Potential Psychedelic Activity.Journal of Natural Products · 2021-03-04Behandeling met psilocybineData Archiving and Networked Services (DANS) · 2021-01-20[Treatment with psilocybin: applications for patients with psychiatric disorders].PubMed · 2021-01-20We Need a Cole Memorandum for Magic MushroomsSSRN Electronic Journal · 2020-12-31Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot studyEClinicalMedicine · 2020-09-23Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of PsilocybinACS Omega · 2020-06-30Psilocybin occasioned mystical-type experiences.Unknown journal · 2020-06-22Psilocybin Therapeutic Research: The Present and Future ParadigmACS Medicinal Chemistry Letters · 2020-03-01Scalable Hybrid Synthetic/Biocatalytic Route to PsilocybinChemistry - A European Journal · 2020-02-25An Improved, Practical, and Scalable Five-Step Synthesis of PsilocybinSynthesis · 2020-01-07Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frameJournal of Contextual Behavioral Science · 2019-11-04Enzymatic Route toward 6-Methylated Baeocystin and PsilocybinChemBioChem · 2019-05-30T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS SurvivorsBiological Psychiatry · 2019-04-30Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMTPLoS ONE · 2019-04-22Emerging from the dark side: new therapeutic applications of scheduled psychoactive substances.Future medicinal chemistry · 2019-01-31Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in Psychology · 2018-12-05Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.Psychopharmacology · 2017-10-29Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.Scientific Reports · 2017-10-12Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.Journal of Psychopharmacology · 2017-10-10Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.Journal of Psychopharmacology · 2016-08-29Antidepressant, Antipsychotic, and Hallucinogen Drugs for the Treatment of Psychiatric Disorders: A Convergence at the Serotonin-2A Receptor.Journal of Psychosocial Nursing and Mental Health Services · 2016-06-30Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Journal of Psychoactive Drugs · 2015-11-22Survey study of challenging experiences after ingesting psilocybin mushrooms: Demographics and phenomenologyDrug and Alcohol Dependence · 2014-12-15The challenging experience questionnaire: Characterization of acute adverse reactions to psilocybinDrug and Alcohol Dependence · 2014-12-15Enhanced repertoire of brain dynamical states during the psychedelic experience.Human Brain Mapping · 2014-07-02The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers.Frontiers in Human Neuroscience · 2014-05-26The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.Frontiers in Human Neuroscience · 2014-02-02PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A2014 REPORTUnknown journal · 2013-12-31Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.Schizophrenia Bulletin · 2012-10-07Magic truffles or Philosopher's stones: a legal way to sell psilocybin?Drug Testing and Analysis · 2012-08-08Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin.The British Journal of Psychiatry · 2012-01-25Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.Proceedings of the National Academy of Sciences · 2012-01-22Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.Psychopharmacology · 2011-06-14Availability of websites offering to sell psilocybin spores and psilocybin.Journal of Psychoactive Drugs · 2009-08-31Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.Journal of Psychopharmacology · 2008-06-30Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.Psychopharmacology · 2006-07-06Patterns of simultaneous polysubstance use in drug using university students.Human Psychopharmacology Clinical and Experimental · 2006-05-31TRAGIC FLYING ATTEMPT UNDER THE INFLUENCE OF "MAGIC MUSHROOMS"Unknown journal · 1999-12-31Skinner, Maslow, and PsilocybinJournal of Humanistic Psychology · 1993-06-30Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.Unknown journal · 1975-07-31The effect of bufotenine, melatonin, psilocybin, and related compounds on the 5-hydroxytryptamine excitatory receptors of Helix aspersa neuronsComparative and General Pharmacology · 1972-02-29ChemInform Abstract: INDOLE 22. MITT. INDOLSYNTH., ANWENDUNG AUF PSILOCINChemischer Informationsdienst. Organische Chemie · 1970-12-21PSILOCYBIN-INDUCED CHANGES IN PSYCHOLOGIC FUNCTION, ELECTROENCEPHALOGRAM, AND LIGHT-EVOKED POTENTIALS IN HUMAN SUBJECTSMayo Clinic Proceedings · 1968-02-29Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteersComprehensive Psychiatry · 1960-11-30